Cargando…
Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex
Biocompatible polymeric materials with potential to form functional structures in association with different therapeutic molecules have a high potential for biological, medical and pharmaceutical applications. Therefore, the capability of the inclusion of nano-Complex formed between the sodium salt...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874715/ https://www.ncbi.nlm.nih.gov/pubmed/29439391 http://dx.doi.org/10.3390/ph11010019 |
_version_ | 1783310216655273984 |
---|---|
author | Salamanca, Constain H. Yarce, Cristhian J. Roman, Yony Davalos, Andrés F. Rivera, Gustavo R. |
author_facet | Salamanca, Constain H. Yarce, Cristhian J. Roman, Yony Davalos, Andrés F. Rivera, Gustavo R. |
author_sort | Salamanca, Constain H. |
collection | PubMed |
description | Biocompatible polymeric materials with potential to form functional structures in association with different therapeutic molecules have a high potential for biological, medical and pharmaceutical applications. Therefore, the capability of the inclusion of nano-Complex formed between the sodium salt of poly(maleic acid-alt-octadecene) and a β-lactam drug (ampicillin trihydrate) to avoid the chemical and enzymatic degradation and enhance the biological activity were evaluated. PAM-18Na was produced and characterized, as reported previously. The formation of polymeric hydrophobic aggregates in aqueous solution was determined, using pyrene as a fluorescent probe. Furthermore, the formation of polymer-drug nano-complexes was characterized by Differential Scanning Calorimetry-DSC, viscometric, ultrafiltration/centrifugation assays, zeta potential and size measurements were determined by dynamic light scattering-DLS. The PAM-18Na capacity to avoid the chemical degradation was studied through stress stability tests. The enzymatic degradation was evaluated from a pure β-lactamase, while the biological degradation was determined by different β-lactamase producing Staphylococcus aureus strains. When ampicillin was associated with PAM-18Na, the half-life time in acidic conditions increased, whereas both the enzymatic degradation and the minimum inhibitory concentration decreased to a 90 and 75%, respectively. These results suggest a promissory capability of this polymer to protect the β-lactam drugs against chemical, enzymatic and biological degradation. |
format | Online Article Text |
id | pubmed-5874715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58747152018-04-02 Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex Salamanca, Constain H. Yarce, Cristhian J. Roman, Yony Davalos, Andrés F. Rivera, Gustavo R. Pharmaceuticals (Basel) Article Biocompatible polymeric materials with potential to form functional structures in association with different therapeutic molecules have a high potential for biological, medical and pharmaceutical applications. Therefore, the capability of the inclusion of nano-Complex formed between the sodium salt of poly(maleic acid-alt-octadecene) and a β-lactam drug (ampicillin trihydrate) to avoid the chemical and enzymatic degradation and enhance the biological activity were evaluated. PAM-18Na was produced and characterized, as reported previously. The formation of polymeric hydrophobic aggregates in aqueous solution was determined, using pyrene as a fluorescent probe. Furthermore, the formation of polymer-drug nano-complexes was characterized by Differential Scanning Calorimetry-DSC, viscometric, ultrafiltration/centrifugation assays, zeta potential and size measurements were determined by dynamic light scattering-DLS. The PAM-18Na capacity to avoid the chemical degradation was studied through stress stability tests. The enzymatic degradation was evaluated from a pure β-lactamase, while the biological degradation was determined by different β-lactamase producing Staphylococcus aureus strains. When ampicillin was associated with PAM-18Na, the half-life time in acidic conditions increased, whereas both the enzymatic degradation and the minimum inhibitory concentration decreased to a 90 and 75%, respectively. These results suggest a promissory capability of this polymer to protect the β-lactam drugs against chemical, enzymatic and biological degradation. MDPI 2018-02-10 /pmc/articles/PMC5874715/ /pubmed/29439391 http://dx.doi.org/10.3390/ph11010019 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Salamanca, Constain H. Yarce, Cristhian J. Roman, Yony Davalos, Andrés F. Rivera, Gustavo R. Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex |
title | Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex |
title_full | Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex |
title_fullStr | Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex |
title_full_unstemmed | Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex |
title_short | Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex |
title_sort | application of nanoparticle technology to reduce the anti-microbial resistance through β-lactam antibiotic-polymer inclusion nano-complex |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874715/ https://www.ncbi.nlm.nih.gov/pubmed/29439391 http://dx.doi.org/10.3390/ph11010019 |
work_keys_str_mv | AT salamancaconstainh applicationofnanoparticletechnologytoreducetheantimicrobialresistancethroughblactamantibioticpolymerinclusionnanocomplex AT yarcecristhianj applicationofnanoparticletechnologytoreducetheantimicrobialresistancethroughblactamantibioticpolymerinclusionnanocomplex AT romanyony applicationofnanoparticletechnologytoreducetheantimicrobialresistancethroughblactamantibioticpolymerinclusionnanocomplex AT davalosandresf applicationofnanoparticletechnologytoreducetheantimicrobialresistancethroughblactamantibioticpolymerinclusionnanocomplex AT riveragustavor applicationofnanoparticletechnologytoreducetheantimicrobialresistancethroughblactamantibioticpolymerinclusionnanocomplex |